85 related articles for article (PubMed ID: 10746803)
1. Oxidation parameters in complete correction of renal anemia.
Ludat K; Sommerburg O; Grune T; Siems WG; Riedel E; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S30-5. PubMed ID: 10746803
[TBL] [Abstract][Full Text] [Related]
2. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
[TBL] [Abstract][Full Text] [Related]
3. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
4. Complete correction of renal anemia by recombinant human erythropoietin.
Ludat K; Paulitschke M; Riedel E; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment.
Siems W; Carluccio F; Radenkovic S; Grune T; Hampl H
Kidney Blood Press Res; 2005; 28(5-6):295-301. PubMed ID: 16534224
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
[TBL] [Abstract][Full Text] [Related]
7. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
8. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
Olszewska M
Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
10. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
Löw I; Grützmacher P; Bergmann M; Schoeppe W
Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
[TBL] [Abstract][Full Text] [Related]
13. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
14. Amino acid and alpha-keto acid metabolism depends on oxygen availability in chronic hemodialysis patients.
Riedel E; Nündel M; Wendel G; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S56-60. PubMed ID: 10746807
[TBL] [Abstract][Full Text] [Related]
15. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
16. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
[TBL] [Abstract][Full Text] [Related]
17. Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.
Berns JS; Rudnick MR; Cohen RM; Bower JD; Wood BC
Kidney Int; 1999 Jul; 56(1):253-60. PubMed ID: 10411700
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte transmembrane electron transfer in haemodialysis patients.
Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
[TBL] [Abstract][Full Text] [Related]
19. [Effect of oxidative stress in patients with chronic renal failure].
González Rico M; Puchades MJ; García Ramón R; Saez G; Tormos MC; Miguel A
Nefrologia; 2006; 26(2):218-25. PubMed ID: 16808260
[TBL] [Abstract][Full Text] [Related]
20. Reduced free radical scavengers and chronic renal failure.
Ong-awyooth L; Ong-ajyooth S; Tiensong K; Nilwarangkur S
J Med Assoc Thai; 1997 Feb; 80(2):101-8. PubMed ID: 9078694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
